Admedus : Investor Presentation

www.admedus.com

Investor Presentation

• This presentation is the property of Admedus Ltd ("Admedus"). No part of this presentation may be reproduced or transmitted in any form or by any means without direct permission in writing from Admedus. This presentation is not and does not constitute an offer, invitation or recommendation to subscribe for, or purchase any security and neither this presentation nor anything contained in it shall form the basis of any contract or commitment.

• This presentation does not constitute an offer, solicitation or invitation in any, state or jurisdiction anywhere, or to any person to whom, such an offer or sale would be unlawful. This presentation is not intended as an offer, invitation, solicitation or recommendation with respect to the purchase or sale of any security in the United States or to any person to whom it is unlawful to make such an offer, invitation or solicitation. Reliance should not be placed on the information or opinions contained in this presentation. This presentation does not take into consideration the investment objectives, financial situation or particular needs of any particular investor. Any decision to purchase or subscribe for securities in Admedus must be made solely on the basis of the information contained in the public domain and if necessary after seeking appropriate financial and legal advice.

• No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, Admedus and its affiliates and related bodies corporate, and their respective officers, directors, employees and agents disclaim any liability (including, without limitation, any liabilities arising from fault or negligence) for any loss arising from any use of this presentation (or its content) or otherwise arising in connection with it. Admedus' forward-looking statements, intentions, forecasts, prospects, returns, expectations, statements in relation to future matters or other forward looking statement contained in this presentation may involve significant elements of subjective judgement and assumptions as to future events which may or may not be correct. There are usually differences between forecast and actual results because events and actual circumstances frequently do not occur as forecast and these differences may be material. They are based on a number of estimates, assumptions that are subject to business, scientific, economic and competitive uncertainties and contingencies, with respect to future business decisions, which are subject to change and, in many cases, are outside the control of Admedus and its directors. Neither Admedus nor its directors give any assurance that the forecast performance in the forecasts or any forward-looking statement contained in this presentation will be achieved.

  1www.admedus.com

  www.admedus.com

  • Company Overview

  • Infusion Business

  • ADAPT® Regenerative Tissue

  • Immunotherapies

  • Company Strategy and Value Proposition

• Rapidly growing healthcare company with best in class products in significant

  medical markets

• Company underpinned by established infrastructure on a global scale and growing revenues

• Revenue reached $14.1M in FY16, an increase of 41.5% on the previous year

• Revenue forecast to grow by >50 in FY17 to at least $21M

• Substantial operating cost improvements underway expected to yield cost savings of $12m in FY17 through

  • 30% reduction in full time employees

  • Manufacturing and operational improvements to drive gross profit margin by 50%

• Material Phase 2 HSV-2 Trial results to be announced in Q4 CY2016 targeting

a $6 Billion yearly market

3www.admedus.com